BioCentury | Oct 3, 2016
Financial News

MS Pharma completes venture financing

...Amman, Jordan Business: Generics, Biosimilars Date completed: 2016-09-26 Type: Venture financing Raised: $50 million Investor: European Bank for Reconstruction and Development WIR...
BioCentury | Apr 11, 2005
Finance

Ebb & Flow

...firm’s third fund for the region. Investors in ACEE III include Teachers’ Private Capital; the European Bank for Reconstruction and Development...
BioCentury | Nov 22, 2004
Company News

Solvay, Petrovax Pharm deal

...fee and is eligible for milestones totaling about E15 million ($19.5 million) loan from the European Bank for Reconstruction and Development...
BioCentury | Nov 18, 2004
Company News

Solvay, Petrovax flu vaccine deal

...Petrovax will pay for construction with a EUR 15 million ($19.5 million) loan from the European Bank for Reconstruction and Development. BC...
Items per page:
1 - 4 of 4
BioCentury | Oct 3, 2016
Financial News

MS Pharma completes venture financing

...Amman, Jordan Business: Generics, Biosimilars Date completed: 2016-09-26 Type: Venture financing Raised: $50 million Investor: European Bank for Reconstruction and Development WIR...
BioCentury | Apr 11, 2005
Finance

Ebb & Flow

...firm’s third fund for the region. Investors in ACEE III include Teachers’ Private Capital; the European Bank for Reconstruction and Development...
BioCentury | Nov 22, 2004
Company News

Solvay, Petrovax Pharm deal

...fee and is eligible for milestones totaling about E15 million ($19.5 million) loan from the European Bank for Reconstruction and Development...
BioCentury | Nov 18, 2004
Company News

Solvay, Petrovax flu vaccine deal

...Petrovax will pay for construction with a EUR 15 million ($19.5 million) loan from the European Bank for Reconstruction and Development. BC...
Items per page:
1 - 4 of 4